| Description |
Today’s pharmaceutical markets are among the most vital segments of the nation’s economy and counterfeit pharmaceuticals are one of the most critical issues facing the industry today. In addition to the obvious impact on the health and well-being of the population, the financial implications for the pharmaceutical industry are enormous, particularly when drug companies spend as much as $800 million to bring a new product to market. Drug counterfeiting and diverting (fraudulently obtaining prescription drugs and reselling them) introduce inefficiencies into the supply chain, dilute company brand names, represent enormous costs to pharmaceutical manufacturers and most of all, expose consumers to health risks via counterfeit dispensing. Unlike packaged goods, pharmaceutical drugs have high market values, unique storage requirements and small unit sizes that make it necessary to track individual bottles or even individual doses. Liability issues, consumer confidence, and brand erosion costs are driving pharmaceutical manufacturers to adopt new technologies to combat this growing global problem.
|
|
